Depression Clinical Trials 2023

What are the top hospitals conducting depression research?

In the realm of mental health, clinical trials are crucial for advancing our understanding and treatment options for conditions such as depression. Let's take a closer look at some top hospitals leading the way in this field. In Tulsa, Oklahoma, the Laureate Institute for Brain Research stands out with its dedication to depression research. Currently conducting two active trials and having completed 16 trials in total since their first recorded trial in 2011, they have been committed to finding innovative solutions for those struggling with depression.

Meanwhile, located in Miami is Relmada Site - a facility that may be newer on the scene but is making significant strides. With two ongoing depression trials and two all-time trials recorded since its inception in 2021, it shows promise as a center focused on tackling this pervasive mental health issue.

The University of New Mexico Family Health Clinic has also prioritized researching ways to alleviate depression symptoms. Their North Valley location in Albuquerque currently hosts two active depression trials while having undertaken two previous investigations since joining the field of clinical therapy just last year (2021). Additionally contributing towards these efforts is their Southeast Heights branch which has mirrored their counterparts' progress through hosting dual current investigations along with an equal tally of previously conducted inquiries.

Further strengthening our fight against depression is Clinica Sierra Vista - Baker Street Village CHC situated in Bakersfield. Although relatively new to conducting clinical trials related to depression when compared to other institutions mentioned before, they too are actively engaged by undertaking two current studies after recording their first-ever trial concerning this condition only earlier this year; reaffirming that even small-scale organizations play significant roles within medical advancements.

These hospitals invest time and resources into research because they understand how vital it is to combat this debilitating condition affecting millions worldwide.It’s important not only for patients seeking relief from depressive symptoms but also for society as a whole. Through collaboration between medical professionals and volunteers participating in these groundbreaking studies we come ever-closer towards developing more effective and targeted treatment options, giving hope to those living with depression.

Which are the best cities for depression clinical trials?

When it comes to depression clinical trials, several cities in the United States offer opportunities for individuals seeking innovative treatments. Among them, Albuquerque, New Mexico stands out with 10 active trials investigating Collaborative Care Plus and other interventions. New York, New York follows closely behind with 8 ongoing studies focusing on REL-1017, SBIRT, and Tele-PROTECT. In San Diego, California, New Mexico stands out with 10 active trials investigating Collaborative Care Plus and other interventions. New York, New York follows closely behind with 8 ongoing studies focusing on REL-1017, SBIRT, and Tele-PROTECT. In San Diego, California and Los Angeles, California there are 7 active trials each exploring treatments like Magnetic Seizure Therapy and Proud & Empowered. Lastly, Baltimore, Maryland offers 6 active trials studying REL-1017 25 mg and Behavioral Activation - Rehabilitation. These cities provide promising prospects for those looking to participate in depression research that may revolutionize care options for millions of people worldwide.

Which are the top treatments for depression being explored in clinical trials?

Ongoing clinical trials are shedding light on the top treatments being explored for depression. Among them, intervention stands out with two active trials and eight all-time depression trials since its first listing in 2009. Equally promising is endotoxin, currently involved in two ongoing trials and showing potential based on four all-time depression studies since 2014. Additionally, new approaches like Amplification of Positivity Therapy and External Qigong are capturing attention as they venture into their inaugural clinical trials for depression. These innovative therapies offer hope for improved outcomes in the treatment of this debilitating condition.

What are the most recent clinical trials for depression?

Recent clinical trials offer new hope for individuals battling depression. A Phase 3 trial investigated the efficacy of REL-1017 at a dosage of 25 mg, showcasing its potential as a treatment option. Additionally, endotoxin was explored in a Phase 1 trial, shedding light on novel approaches to addressing depressive symptoms. The effectiveness and safety of brexanolone were examined in a Phase 4 study, providing valuable insights into this medication's role in managing depression. Furthermore, duloxetine showcased promise as an intervention for depression during its Phase 2 trial. With these recent advancements paving the way forward, there is renewed optimism for improved outcomes and support for those living with depression.

What depression clinical trials were recently completed?

Recent clinical trials have made significant strides in the field of depression treatment. These include a trial conducted by Alto Neuroscience, which investigated the ALTO-100 PO Tablet and concluded in June 2022. Another notable study led by Washington University School of Medicine explored the efficacy of Ketamine and was completed in April 2022. Additionally, Rebecca Price sponsored a trial on Intravenous Ketamine that reached completion in February 2022. These advancements serve as promising developments for individuals struggling with depression, emphasizing ongoing efforts to find innovative therapeutic approaches.